You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 5, February 3, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Risk of Developing AIDS in HIV-Infected Cohorts of Hemophilic and Homosexual Men

Janine Jason, MD; Kung-Jong Lui, PhD; Margaret V. Ragni, MD; Nancy A. Hessol, MSPH; William W. Darrow, PhD

JAMA. 1989;261(5):725-727.


Abstract

The latency period and/or incidence of the acquired immunodeficiency syndrome (AIDS) may differ in persons infected with the human immunodeficiency virus by different routes or having different "cofactors." We compared 79 hemophilic men in Pennsylvania and 117 homosexual and bisexual men in California, all having known dates of infection and long postinfection observation periods, to examine these hypotheses. By 1987, twenty-one percent of the hemophilic and 27% of the homosexual men had developed AIDS. However, seroconversion patterns differed for the two groups, and when this was taken into account, the conditional odds ratio for AIDS was 1.20. Kaplan-Meier survival analysis showed no significant difference in the cumulative proportion with AIDS, from time of infection. These results are limited by the small size and geographically localized nature of our study populations, but they suggest that currently the relative length of human immunodeficiency virus infection is of primary importance in comparing disease outcome for different populations.

(JAMA 1989;261:725-727)



Author Affiliations

From the Division of Host Factors, Center for Infectious Diseases (Dr Jason), and the Division of Injury Epidemiology and Control, Center for Environmental Health and Injury Control (Dr Lui), Centers for Disease Control, Atlanta; the Department of Medicine, University of Pittsburgh, and Central Blood Bank of Pittsburgh (Dr Ragni); the AIDS Office, Department of Public Health, San Francisco (Ms Hessol); and the AIDS Program, Center for Infectious Diseases, Centers for Disease Control, Atlanta (Dr Darrow).


Footnotes

Reprint requests to the Epidemiology Studies Section, Division of Host Factors, Centers for Disease Control, CID, 1600 Clifton Rd, 1/1343, D02, Atlanta, GA 30333 (Dr Jason).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Replication-Defective Canarypox (ALVAC) Vectors Effectively Activate Anti-Human Immunodeficiency Virus-1 Cytotoxic T Lymphocytes Present in Infected Patients: Implications for Antigen-Specific Immunotherapy
Ferrari et al.
Blood 1997;90:2406-2416.
ABSTRACT | FULL TEXT  

Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion
Pezzotti et al.
BMJ 1996;313:583-586.
ABSTRACT | FULL TEXT  

Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection
Cao et al.
NEJM 1995;332:201-208.
ABSTRACT | FULL TEXT  

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 106/l, AIDS, and death from AIDS?
Lindback et al.
BMJ 1994;309:1535-1537.
ABSTRACT | FULL TEXT  

Direct Comparison of the Relationship Between Clinical Outcome and Change in CD4+ Lymphocytes in Human Immunodeficiency Virus--Positive Homosexual Men and Injecting Drug Users
Margolick et al.
Arch Intern Med 1994;154:869-875.
ABSTRACT  

Transmission of Human Immunodeficiency Virus Type 1 (HIV-1) by Exposure to Blood: Defining the Risk
Klein and Friedland
ANN INTERN MED 1990;113:729-730.
ABSTRACT  

Longitudinal Study of 94 Symptomatic Infants With Perinatally Acquired Human Immunodeficiency Virus Infection: Evidence for a Bimodal Expression of Clinical and Biological Symptoms
Blanche et al.
Arch Pediatr Adolesc Med 1990;144:1210-1215.
ABSTRACT  

The Risk of Developing AIDS in Hemophiliac and Homosexual Men
Warth
JAMA 1989;262:3129-3130.
ABSTRACT  

Modeling the Spread of HIV
Salzberg et al.
JAMA 1989;262:1329-1330.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.